本页面由Tiger Trade Technology Pte. Ltd.提供服务

天演药业

3.14
-0.1000-3.09%
盘后3.140.00000.00%16:10 EST
成交量:6.41万
成交额:20.61万
市值:1.48亿
市盈率:-4.89
高:3.38
开:3.19
低:3.07
收:3.24
52周最高:3.53
52周最低:1.30
股本:4,713.13万
流通股本:1,273.25万
量比:0.92
换手率:0.50%
股息:- -
股息率:- -
每股收益(TTM):-0.6428
每股收益(LYR):-0.7423
净资产收益率:-63.26%
总资产收益率:-24.89%
市净率:3.90
市盈率(LYR):-4.23

数据加载中...

2025/05/28

SEC问询函

Form CORRESP - Correspondence
2025/05/23

SEC问询函

Form CORRESP - Correspondence
2025/03/24

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/07

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/03/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/19

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/10

SEC问询函

Form CORRESP - Correspondence
2023/06/16

SEC问询函

Form CORRESP - Correspondence
2023/04/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/05/24

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/13

SEC问询函

CORRESP [Cover] - Correspondence
2022/04/29

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/04/26

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals